AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

CAS 7682-20-4 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 7682-20-4
Also known as: 7682-20-4, (s)-2-aminobutyramide hydrochloride, H-abu-nh2 hcl, (s)-2-aminobutanamide hydrochloride, L-2-aminobutanamide hydrochloride, (s)-(+)-2-aminobutanamide hydrochloride
Molecular Formula
C4H11ClN2O
Molecular Weight
138.59  g/mol
InChI Key
HDBMIDJFXOYCGK-DFWYDOINSA-N
FDA UNII
2C1V4527RJ

1 2D Structure

CAS 7682-20-4

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-aminobutanamide;hydrochloride
2.1.2 InChI
InChI=1S/C4H10N2O.ClH/c1-2-3(5)4(6)7;/h3H,2,5H2,1H3,(H2,6,7);1H/t3-;/m0./s1
2.1.3 InChI Key
HDBMIDJFXOYCGK-DFWYDOINSA-N
2.1.4 Canonical SMILES
CCC(C(=O)N)N.Cl
2.1.5 Isomeric SMILES
CC[C@@H](C(=O)N)N.Cl
2.2 Other Identifiers
2.2.1 UNII
2C1V4527RJ
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 7682-20-4

2. (s)-2-aminobutyramide Hydrochloride

3. H-abu-nh2 Hcl

4. (s)-2-aminobutanamide Hydrochloride

5. L-2-aminobutanamide Hydrochloride

6. (s)-(+)-2-aminobutanamide Hydrochloride

7. (2s)-2-aminobutanamide;hydrochloride

8. L-2-aminobutanamide, Hcl

9. Butanamide, 2-amino-, Monohydrochloride, (2s)-

10. L-homoalanylamide Hcl

11. 141978-61-2

12. 2c1v4527rj

13. Levetiracetam Related Compound B [usp-rs]

14. Butanamide, 2-amino-, Monohydrochloride, (s)-

15. Butanamide, 2-amino-, Hydrochloride (1:1), (2s)-

16. H-abu(2)-nh2 Hcl

17. (s)-2-aminobutanamide Hcl

18. (s)-2-amino Butanamide Hcl

19. (s)-2-amino-butanamide Hcl

20. Mfcd00136565

21. H-abu-nh2hcl

22. (s)-2-amino-butanamide Hydrochloride

23. S (+)-2-aminobutyramide Hydrochloride

24. L-2-aminobutanamide Hcl

25. Schembl373444

26. Unii-2c1v4527rj

27. L-homoalanylamide Hydrochloride

28. (s)-2-amino-butylactamide Hcl

29. Dtxsid10474839

30. S-2-aminobutanamide Hydrochloride

31. Act02761

32. Cs-b0864

33. H-abu-nh2 Hydrochloride, Aldrichcpr

34. Akos015910759

35. Ds-1209

36. Butanamide,2-amino-,hydrochloride(1:1)

37. Ac-23986

38. Am20100759

39. (s)-2-aminobutanamide Hydrochloride [usp-rs]

40. (s)-(+)-2-aminobutanamide Hydrochloride, 97%

41. 682a204

42. A935960

43. (2s)-2-aminobutanamide--hydrogen Chloride (1/1)

44. Butyramide, 2-amino-, Monohydrochloride, L-

45. Q-102786

46. Levetiracetam Related Compound B, United States Pharmacopeia (usp) Reference Standard

2.4 Create Date
2006-12-11
3 Chemical and Physical Properties
Molecular Weight 138.59 g/mol
Molecular Formula C4H11ClN2O
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass138.0559907 g/mol
Monoisotopic Mass138.0559907 g/mol
Topological Polar Surface Area69.1 Ų
Heavy Atom Count8
Formal Charge0
Complexity72.1
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
Flag China
Digital Content Digital Content
URL Supplier Web Content
7682-20-4
Levetiracetam
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
7682-20-4
Brivaracetam
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY